THE SILVER LINING
Los Angeles BioSciences’ lead product, LABS Ag, is a silver-impregnated synthetic dermal scaffold designed to support partial and full-thickness layer defects and wound management across acute and complex clinical settings. LABS Ag is engineered to provide structural dermal support, predictable handling, and workflow compatibility in burn centers, trauma care facilities, and hospital environments.
LABS Ag is engineered in collaboration with industry-leading burn and microsurgical plasticand reconstructive surgeons, as well as polymer chemists and medical technology innovators. Its synthetic scaffold is designed for flexibility and close tissue apposition, supporting conformity across complex wound geometries. The scaffold architecture is intended to help organize the wound bed and support controlled tissue response during wound management.
LABS Ag is designed to be sterile, single-use, biodegradable, non-toxic, and non-irritating to tissue.
It is intended for use during acute and subacute phases of wound management.
WHY SILVER?
LABS Ag incorporates silver as part of its material composition to support localized antimicrobial management while maintaining biocompatibility and predictable handling characteristics.
- Designed to discourage microbial adherence within the scaffold structure
- Engineered for consistent handling during placement
- Suitable for storage at ambient temperatures
- Provided in a sterilized state
- Biodegradable and biocompatible
WHY SYNTHETICS?
LABS Ag’s dermal scaffolds are fully synthetic, enabling material consistency, durability, and scalable manufacturing without the constraints associated with biologic materials. The bilayer architecture is engineered to address the practical demands of complex wound environments and support surgical decision-making over time.
- No preparation at point of use
- Physically inert and non-biologic, designed to avoid serving as a nutritional substrate for microbial growth
- Mechanically durable, supporting resistance to shear forces during handling and placement
- Stable for shipping and storage at room temperature, without cold-chain requirements
- Viable at high-heat temperatures
- Manufactured with consistency to support predictable use across clinical settings
- Designed to support management of highly exudative wounds by maintaining structural integrity with fenestrations
- Engineered to limit evaporative loss and reduce oxidative stress at the wound surface, and support a controlled wound healing environment
- Supports optionality in wound management, including staged reconstruction or secondary intention healing
A NEW ERA IN BURN SOLUTIONS
LABS Ag is engineered to deliver practical, workflow-aligned support across the clinical journey, from initial wound management through ongoing surgical decision-making.
For Surgeons
- Designed to support predictable handling and flexible surgical decision-making across complex and evolving wound scenarios.
- Provides a stable, adaptable scaffold that supports time and optionality when managing staged or evolving reconstructions.
For Care Teams
- Built to simplify wound management and reduce variability at the bedside.
- Requires no specialized storage, preparation, or reconstitution.
For Patients
- Designed to support a controlled wound environment during the healing process.
- Material and structural design intended to support tissue management during recovery.
For Hospitals
- Designed to integrate into existing clinical workflows without specialized storage or preparation requirements.
- Synthetic, scalable manufacturing supports predictable supply and operational planning.
A FUTURE OF INNOVATION
LABS Ag is just the beginning. Los Angeles BioSciences is committed to leveraging synthetic materials to enable iterative innovation across medical technologies.
- Synthetic platform enables the agility of future material and design enhancements without biologic constraints.
- Modular architecture supports potential future product extensions and indications, subject to regulatory clearance.